NEURO61

Session information

[held on paper]Oral Session

[O-22] Oral Session 22
Dementia (biomarker)

Shigenori Kanno1,2, Yoichi Ogawa3, Hiroaki Arai4, Satoru Otomo4, Hiroaki Kikuchi5, Satoshi Shibuya2,6, Kyoko Suzuki1 (1.Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku Univeristy Graduate School of Medicine, 2.Department of Neurology, South Miyagi Medical Center, 3.Department of Radiology, South Miyagi Medical Center, 4.Department of Neurosurgery, South Miyagi Medical Center, 5.Healthcare Center, South Miyagi Medical Center, 6.Department of Internal Medicine, Moriyama Memorial Hospital)

Nagato Kuriyama1, Teruhide Koyama1, Etsuko Ozaki1, Satoshi Saito4, Masafumi Ihara4, Daisuke Matsui1, Isao Watanabe1, Mutsumi Umehara2, Masaki Kondo2, Toshiki Mizuno2, Yoshinori Marunaka5, Akihiro Takada5, Kentaro Akazawa3, Kei Yamada3, Satomi Tomida1, Reo Nagamitsu1, Fumitaro Miyatani1, Masahiro Miyake6, Yoshiyuki Watanabe1,7, Ritei Uehara1 (1.Departments of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2.Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan, 4.Department of Stroke and Cerebrovascular Diseases, Division of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan, 5.Kyoto Industrial Health Association, Kyoto, Japan, 6.Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan, 7.Faculty of Health and Medical Sciences,Kyoto University of Advanced Science)

Keisuke Morihara1, Yuichi Higashiyama1, Shiori Asano1, Yuki Matsunaga1, Keita Takahashi1, Ryoko Miyake1, Kenichi Tanaka1, Katsuo Kimura2, Hitaru Kishida2, Naohisa Ueda2, Hideto Joki1, Hiroshi Doi1, Hideyuki Takeuchi1, Fumiaki Tanaka1 (1.Department of Neurology and Stroke medicine, Yokohama City University, 2.Department of Neurology, Yokohama City University Medical Center)

Kensaku Kasuga1, Tamao Tsukie1, Masataka Kikuchi2, Norikazu Hara1, Akinori Miyashita1, Ryozo Kuwano3, Takeshi Iwatsubo4, Takeshi Ikeuchi1, Japanese Alzheimer's Disease Neuroimaging Intiative1 (1.Department of Molecular Genetics, Brain Research Institute, Niigata University, 2.Department of Genome Informatics, Graduate School of Medicine, Osaka University, 3.Asahigawaso Medical-Welfare Center, Asahigawaso Research Institute, 4.Department of Neuropathology, Graduate School of Medicine, The University of Tokyo)

Yuhei Takado1, Kenji Tagai1, Kiwamu Matsuoka1, Hitoshi Shinoto1, Yasunori Sano1, Keisuke Takahata1, Manabu Kubota1, Maiko Ono1, Naruhiko Sahara1, Takayuki Obata1, Kazunori Kawamura2, Ming-rong Zhang2, Tetsuya Suhara1, Hitoshi Shimada1, Makoto Higuchi1 (1.Department of Functional Brain Imaging Research, National Institutes for Quantum and Radiological Science and Technology, 2.Department of Radiopharmaceuticals Development, National Institutes for Quantum and Radiological Science and Technology)

Akira Kuzuya1, Masakazu Miyamoto1, Yamamoto Yosuke2, Noriko Uchida1, Atsuko Kokuryu1, Naohiro Egawa1, Atae Kinoshita3, Shunichi Fukuhara2, Ryosuke Takahashi1 (1.Department of Neurology, Kyoto University Graduate School of Medicine, 2.Department of Healthcare Epidemiology, Kyoto University Graduate School of Medicine, 3.Department of Human Health Sciences, Kyoto University Graduate School of Medicine)